. The binding residues are shown in stick representation. Substrate binding loops L1-L4 are color coded according to the B-factor whereas lighter color correlates to higher B-factor. The leucine residue of the LRSR inhibitor (probe 2) fits perfectly in the substrate binding pocket S4 indicated by the dark blue L4 loop of the probe 2 bound crystal structure. The alkyne tail is hardly visible in electron density, which might be explained by the fact that the linker is not directly bound to the protein and therefore more flexible. B) Detection of overexpressed MALT1 activity. Fluorescent MALT1-ABP labels active MALT1 in a gel-based assay, but not the mutant. Jurkat T cells, transfected with active FLAG-MALT1 wt or active site mutant C464A, were stained after lysis and FLAG-IP with probe 2, pre-clicked to TAMRA. After separation by SDS-PAGE, analysis was done by fluorescence scanning (MALT1-ABP) and western blot. C) MALT1 wt and mutant as well as A20 were overexpressed. MALT1 cleavage of A20, a natural substrate of MALT1, was analyzed by western blot. (Carma1 deficient Jurkat T cells) were transfected with CARMA1 wt or S645A mutant, stimulated, lysed and MALT1 activity was analyzed after MALT1 precipitation within an in vitro cleavage assay using the substrate Ac-LRSR-AMC. Protein expression was analyzed by Western Blot. Data are shown as mean ± SD (three independent experiments). B) Size exclusion chromatography was used to separate protein complexes from unstimulated or stimulated Jurkat T cells. Pooled fractions were subjected to BCL10-IP and analysed by western blot. Only in fraction A, the high molecular CBM complex is present and CARMA1 and MALT1 can be co-precipitated with BCL10.
Supplemental Experimental Procedures
Reagents for chemical synthesis
(all Creosalus), 5-hexynoic acid, diazald, isobutyl chloroformate, N-methylmorpholine, potassium fluoride, dimethyl benzoic acid, fluorescein-isothiocyanate (all Sigma-Aldrich).
Chemical synthesis of ABPs
For the synthesis of the AOMK ABPs, we first used a combined solid phase/solution phase synthesis, which constructs the peptide recognition element on a chlorotrityl resin and installs the dimethyl benzoic acid leaving group in the final steps (Blum, et al., 2005 ketone) was formed. We next followed a solid phase protocol reported by Kato et al (Kato, et al., 2005) . In brief, resin-bound intermediate 3 was elongated with 5% diethyl amine (DEA) in DMF for Fmoc deprotection, followed by a DIC/HOBt-mediated amino acid coupling. After final capping of the N-terminus with FITC, the probe was cleaved from the resin and analyzed by LC-MS. Unfortunately, the dimethyl benzoic acid group of the AOMK electrophile was substituted by DEA. Displacement of the acyloxy group of AOMKs by nitrogen bases is a known problem (Kato, et al., 2005) , and repeated Fmoc-deprotection by DEA is apparently not compatible with the dimethylbenzoic acid group. To facilitate a successful solid phase synthesis, we used 0.1 M tetrabutylammonium fluoride (TBAF) to deprotect the Fmoc-group (Ueki and Amemiya, 1987) .
Under these conditions, the dimethyl benzoyl group is stable. During the first attempt using this synthesic route, we noticed that cleavage from the resin directly followed by HPLC purification led to a contamination of the probe with tetrabutylammonium ions. Hence, after final Fmocdeprotection, we extensively washed the resin with MeOH, DMF and DCM, then cleaved the AOMK from the resin and precipitated it in cold ether. For probes 5 and 6, we then reacted the precipitate with FITC (1.1 eq) or BODIPY-FL, succinimidyl ester (1.1 eq), and DIEA (3 eq) in dmso. After 2h, the reaction mixture was purified by RP-HPLC (20-60% gradient of acetonitrile in water + 0.1% TFA), yielding probes 5 (7.6%), 6 (3.5%) and 7 (1.9; yields based on Fmoc- 
(calculated).

Click chemistry
Copper(I)-catalyzed click chemistry reaction was performed in 50 μl 50 mM hepes with 10 μM alkyne-LRSR-AOMK (probe 2) and 10 μM N-TAMRA-3-aminopropylazide or 100 μM N-FITC-3-aminopropylazide. Reducing agent sodium ascorbate (0.5 mM), TBTA (50 μM) and CuSO 4 (1 mM) were added to the reaction and incubated for 45 min at RT.
Cloning, expression and purification
Human MALT1 (L339-R719) was cloned into the pET21a (Novagen) vector using Nde1 and Xho1 restriction sites. The protein was expressed in Escherichia coli Rosetta™ (DE3) strain (Novagen). Cells were lysed by sonication in lysis buffer (50 mM hepes pH=7.5, 300 mM NaCl, 7 mM imidazol and 4 mM β-mercaptoethanol). The MALT1 protein was further purified by Ni-NTA affinity chromatography (Qiagen) and size exclusion chromatography (S200 26/60, GEHealthcare). Monomeric MALT1 was concentrated to 8 mg/ml in size-exclusion-buffer (25 mM hepes pH=7.5, 300 mM NaCl, 5 mM DTT) and further incubated with twofold molar excess of the peptide inhibitors at 10 °C overnight. After additional size exclusion chromatography (S200 16/60 GE-Healthcare) dimeric MALT1 bound to the tetrapeptide inhibitors was concentrated to 6 mg/ml.
Crystallization
Crystals of z-VRPR-FMK bound to MALT1 were obtained in the published condition (Yu, et al., 2011) . These crystals were used for streak-seeding to obtain alkyne-LRSR-AOMK bound crystals by using the reservoir solution (25 mM MES pH=5.5, 75 mM calcium acetate, 10 % benzamidine hypochloride). Crystals were cryo protected with 15 % 2,3-butandiol in reservoir solution and flash frozen with liquid nitrogen.
X-ray data collection, structure determination and refinement
Data collection of crystals with alkyne-LRSR-AOMK bound to MALT1 (L339-R719) was performed on the X06SA beamline (Swiss Light Source, Villingen). Data were processed by XDS (Kabsch, 1993) . The structure of alkyne-LRSR-AOMK bound to MALT1 was determined at 2.4 Å resolution by molecular replacement with PHASER (McCoy, et al., 2007) using the z-VRPR-FMK bound MALT1 structure (pdb entry: 3UOA) as search model (Yu, et al., 2011) .
The model was refined with Phenix (Adams, et al., 2010) and finally shows 734 (96.45 %) residues in the preferred region of the ramachandran plot, 26 (3.42 %) residues fall in the allowed region, and 1 (0.13 %) residue are outliers. Figures for this publication were generated in PyMol (Schrodinger, 2010) . The hexynoyl group/tail was not visible in the electron density and probably flexible due to lacking interactions to the MALT1 active site loops.
Values in parentheses are for the highest resolution shell.
R=Σ|Fobs-Fcalc|/ΣFobs, where Fcalc is the calculated protein structure factor from the atomic model. 
ABP labeling after immunoprecipitation (IP)
Cells were lysed in 500 μl co-IP buffer without protease inhibitors (25 mM hepes pH 7.5, 150
mM NaCl, 0.2% NP-40, 10% glycerol, 1 mM DTT, 10 mM sodium fluoride, 8 mM β-glycerophosphate and 300 μM sodium vanadate), centrifuged (14000 rpm, 10 min, 4°C) and overexpressed FLAG MALT1 was immunoprecipitated by FLAG (M2) antibody for 3 hours at Plasmids and siRNA N-terminal FLAG-A20 constructs, C-terminal CARMA1-FLAG-Strep-Strep constructs (wt or S645A), N-terminal FLAG-(or HA-) MALT1 wt and active site mutant constructs were cloned in the pEF backbone vector (Invitrogen). siRNAs were purchased from Eurogentec (siMALT1:
UCACUGUGUUACUGGAUGA).
Cell transfection and transduction
Jurkat T cells and JPM50.6 (8x10 6 ) cells were transfected with 6 μg DNA by electroporation in a GenePulser Xcell (BioRad). For siRNA experiments, Jurkat T cells were transfected with 100 nM siRNA and Atufect transfection reagent (Silence Therapeutics, Berlin). BJAB cells were stably transduced with lentiviral CARMA1 expression constructs and protocols were used according to
Hadian et al (Hadian, et al., 2011) . Infection rates of BJAB cells were monitored by anti hCD2-APC (eBioscience) staining in flow cytometry.
Protease cleavage assays
For detecting MALT1 cleavage, recombinant GST-MALT1 wt (N-terminal GST) was expressed and purified from E.coli and MALT1 cleavage assay was performed as described in Nagel et al (Nagel, et al., 2012) . In brief, 200 ng GST-MALT1 together with probe 2, 5, 6, 7, z-VRPR-FMK, mepazine or CA-074 was incubated with 50 µM Ac-LRSR-AMC substrate for 2h at 30°C.
Alternatively, precipitated overexpressed HA-MALT1 wt or mutant was used. Assay was performed in cleavage buffer (50 mM MES, 1 M sodium citrate pH 7, 150 mM NaCl, 10 % sucrose, 0.1 % chaps, 10 mM DTT). For Caspase 8 0.1 Unit recombinant caspase 8 together with inhibitors was incubated with 50 µM DEVD-AMC substrate using the same experimental conditions as for MALT1 cleavage. For cathepsin B cleavage, 0.2 ng of enzyme was incubated with 50 µM zRR-AMC substrate for 2h at 30°C. Assay was performed in 0.1 M sodium acetate pH 5.5, 10 mM DTT and 0.1 mM EDTA. AMC fluorescence was measured in a Synergy 2
Microplate Reader (Biotek).
